1.89
전일 마감가:
$1.86
열려 있는:
$1.85
하루 거래량:
25,187
Relative Volume:
0.43
시가총액:
$74.01M
수익:
$57,000
순이익/손실:
$-32.14M
주가수익비율:
-2.923
EPS:
-0.6466
순현금흐름:
$-27.58M
1주 성능:
-5.50%
1개월 성능:
+9.88%
6개월 성능:
-47.35%
1년 성능:
+2.72%
Sera Prognostics Inc Stock (SERA) Company Profile
명칭
Sera Prognostics Inc
전화
(801) 990-0520
주소
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SERA
Sera Prognostics Inc
|
1.89 | 72.05M | 57,000 | -32.14M | -27.58M | -0.6466 |
|
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 개시 | Jefferies | Buy |
| 2022-03-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | Oppenheimer | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
Sera Prognostics Inc 주식(SERA)의 최신 뉴스
SERA (NASDAQ: SERA) CCO sells 4,739 shares to cover RSU tax withholding - Stock Titan
Sera Prognostics (NASDAQ: SERA) CFO sells shares to cover RSU tax obligations - Stock Titan
SERA PROGNOSTICS (NASDAQ: SERA) CEO tax-related share sale disclosed - Stock Titan
SERA (NASDAQ: SERA) CMO executes 362-share tax sell-to-cover trade - Stock Titan
SERA (SERA) General Counsel sells 2,179 shares to cover RSU taxes - Stock Titan
SERA (NASDAQ: SERA) — Proposed sale of 2,179 Class A shares on 06/11/2026 - Stock Titan
Sera Prognostics Q1 2026 Earnings: In-Line EPS as Company Advances Proteomic PlatformEstimate Revision Count - newsline.com
Sera Prognostics CEO Lindgardt sells $43,170 in company stock By Investing.com - Investing.com Canada
Sera Prognostics CEO Lindgardt sells $43,170 in company stock - Investing.com UK
[Form 4] SERA PROGNOSTICS, INC. Insider Trading Activity - Stock Titan
Sera Prognostics (SERA) CFO sells shares to cover RSU tax obligations - Stock Titan
Proposed Class A Common resale — SERA (NASDAQ: SERA) 06/09/2026 - Stock Titan
Insider Sell: Sandra Lawrence Sells Shares of Sera Prognostics I - GuruFocus
Director at Sera Prognostics (SERA) sells 1,560 planned shares - Stock Titan
Sera Prognostics (SERA) Q4 2025 Earnings Call Transcript - MLQ.ai
[144] SERA PROGNOSTICS, INC. SEC Filing - Stock Titan
Sera Prognostics, Inc. 8-K SEC Filing June 2026 – Submission of Matters to a Vote of Security Holders - Minichart
SERA Stock Coverage Initiated with Buy Rating and $6 Target - GuruFocus
Sera Prognostics Holds 2026 Annual Stockholders Meeting - TipRanks
Sera Prognostics (NASDAQ: SERA) 2026 meeting backs board and Ernst & Young - Stock Titan
No trades reported as Sera Prognostics (NASDAQ: SERA) director files Form 4 - Stock Titan
SERA Initiated Coverage by Craig-Hallum -- Price Target Set at $6.00 - GuruFocus
Sera Prognostics (SERA) Surges on Renewed Buying Interest, Tests Key ResistanceFRAMA Signal - newsline.com
Craig-Hallum Initiates Sera Prognostics(SERA.US) With Buy Rating, Announces Target Price $6 - Moomoo
Sera Prognostics Announces Board Member Jeff Elliott’s Resignation and Upcoming Board Appointment - Minichart
Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Jackson Benjamin - Moomoo
Sera Prognostics Announces Board Resignation and Transition Plan - TipRanks
Jeffrey T. Elliott resigns from Sera Prognostics board, effective June 4, 2026 - TradingView
Sera Prognostics (NASDAQ: SERA) counsel adds 5,000 ESPP shares in Form 4 filing - Stock Titan
Sera Prognostics (SERA) CCO adds 3,168 shares through employee stock plan - Stock Titan
Sera Prognostics director Jeff Elliott to step down Wednesday - Investing.com
Sera Prognostics (NASDAQ: SERA) plans new board appointment - Stock Titan
Sera Prognostics director Jeff Elliott to step down Wednesday By Investing.com - Investing.com South Africa
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION - PR Newswire
Sera Prognostics, Inc. Announces Jeff Elliott Steps Down from Board of Directors, Effective June 4, 2026 - marketscreener.com
SERA Q1 2026 Earnings Transcript - AOL.com
Sera Prognostics (SERA) Edges Higher, Testing Key Resistance at $2.28ATR Stop - newsline.com
Sera Prognostics (SERA) Slips 2.28% as Stock Tests Key Support LevelsVWAP Bounce - The Legal Advocate
Sera Prognostics (SERA) Slips 2.3% Amid Low Volume; Key Support at $2.03 in FocusParabolic SAR - The Legal Advocate
Sera Prognostics Surges 15%: Bullish Momentum Meets Key Resistance at $2.17Composite Profile - The Legal Advocate
Sera Prognostics Q1 2026 Earnings: In-Line Loss, No Revenue, Stock Surges 15%Estimate Dispersion - newsline.com
Sera Prognostics Q1 2026 Earnings: In-Line Loss and No Revenue as Stock Surges on Pipeline Progress - Newser
Sera Prognostics Q1 2026 Earnings: EPS In Line with Estimates as Stock Rises 15%Community Trading Platform - Newser
Sera Prognostics Q1 2026 Earnings: EPS Matches Estimates, Stock Surges 15% on Strategic ProgressGlobal Trading Community - Newser
Sera Prognostics Moves Up 15% Just Ahead of Holiday - Bez Kabli
Sera Prognostics Surges 15%: Key Resistance in Sight for SERATrading Community - Newser
Sera Prognostics (SERA) Q1 2026 In Line: What's Next for InvestorsMargin Expansion Trends - Newser
Sera Prognostics (SERA) Q1 2026 Earnings Preview: What to ExpectAnalyst Consensus Shift - newsline.com
Sera Prognostics (SERA) Surges +0.85%, Nearing $1.86 Resistance 2026-05-19PSAR Stop - newsline.com
Sera Prognostics (SERA) loses 27% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Number of shareholders of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Sera Prognostics Inc (SERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sera Prognostics Inc 주식 (SERA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Aerts Austin | Chief Financial Officer |
Jun 11 '26 |
Sale |
2.01 |
2,037 |
4,094 |
301,190 |
| Lindgardt Zhenya | Chief Executive Officer |
Jun 11 '26 |
Sale |
2.01 |
6,990 |
14,050 |
865,009 |
| Inglis Tiffany Eul Davis | Chief Medical Officer |
Jun 11 '26 |
Sale |
2.01 |
362 |
728 |
92,075 |
| Jackson Benjamin | General Counsel |
Jun 11 '26 |
Sale |
2.01 |
2,179 |
4,380 |
161,756 |
자본화:
|
볼륨(24시간):